Related Experiment Videos
When symptoms persist: clozapine augmentation strategies
1Department of Psychiatry, Medical College of Georgia, Augusta 30912, USA. Pbuckley@mail.mcg.edu
Schizophrenia Bulletin
|February 5, 2002
Summary
Optimizing clozapine monotherapy is key for treatment-resistant schizophrenia. Augmentation strategies offer modest benefits, but more rigorous trials are needed to guide treatment for clozapine nonresponders.
Area of Science:
- Psychiatry
- Pharmacology
Background:
- Clozapine is effective for treatment-refractory schizophrenia but many patients remain symptomatic.
- Optimizing clozapine monotherapy is the initial management step for nonresponders.
Purpose of the Study:
- To synthesize the literature on clozapine augmentation strategies for patients with persistent symptoms despite monotherapy.
- To evaluate the efficacy of various adjunctive treatments.
Main Methods:
- Literature synthesis of available studies on clozapine augmentation.
- Review of treatment options including antipsychotics, mood stabilizers, SSRIs, glycinergic agents, and ECT.
Main Results:
- Evidence comparing augmentation strategies is limited.
- Adjunctive therapies generally provide only modest clinical improvement.
- The literature primarily consists of case series and open-label trials.
Conclusions:
- Further research, particularly double-blind trials, is needed to establish the efficacy of specific clozapine augmentation strategies.
- Systematic investigation of adjunctive therapies is warranted for improving treatment outcomes in clozapine nonresponders.